NCT00141661 - A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Alzheimer Disease

Interventions

DRUG

PF-04494700 - Low Dose Arm

30 mg loading dose for 6 days, followed by 10 mg daily

DRUG

PF-04494700 - High Dose Arm

60 mg loading dose for 6 days, followed by 20 mg daily

DRUG

Placebo Comparator

Matching placebo.

Trial Locations (12)

Pfizer Investigational Site, Jacksonville

Pfizer Investigational Site, Orlando

Pfizer Investigational Site, Hallandale

Pfizer Investigational Site, Fort Lauderdale

Pfizer Investigational Site, West Palm Beach

Pfizer Investigational Site, Largo

Pfizer Investigational Site, Fort Myers

Pfizer Investigational Site, Memphis

Pfizer Investigational Site, Sun City

Pfizer Investigational Site, San Diego

Pfizer Investigational Site, Fresno

Pfizer Investigational Site, San Francisco